JOHNS HOPKINS UNIVERSITY

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

• Anti-Tamper Technology Executive Agency0605024Fmatched: “Executive|Agency”matched 2+ title words

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens…

Lobbying activities7

• Budget/AppropriationsBUD

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• EducationEDU

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• Financial Institutions/Investments/SecuritiesFIN

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• Health IssuesHCR

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• Medical/Disease Research/Clinical LabsMED

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• Medicare/MedicaidMMM

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

• Taxation/Internal Revenue CodeTAX

  Advised on fiscal year 2024 appropriations; Medicare outpatient reimbursement; Graduate Medical Education; Childrens Hospital Graduate Medical Education; the Lower Cost, More Transparency Act, H.R. 5378; price transparency; telehealth; the Preventive Health Savings Act, H.R. 766/S.114; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions Act, H.R.5933; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; clinical trials; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; and Executive branch Fellowships.

Lobbyists3

• CARLOS JACKSONrevolving door

  Legislative Assistant; House Member Office (Rep. Gwen Moore), Executive Assistant, Special Projects Coordinator, House Member Office (Kleczka)

• MICHAEL SMITH
• ROBIN JULIANOrevolving door

  Staff Dir House Approps Cmte; Clerk House Labor-HHS Subcmte; Prof Staff House Labor-HHS Subcmte; Sr Policy Advr, Natl Economic Council, Exec Office of Pres; Prof Staff Senate Labor-HHS Subcmte; Educ Policy Advr HELP Cmte; Sr.LA(Sanders);LA(Mikulski)